MA
JNJ icon

Maxele Advisors’s Johnson & Johnson JNJ Stock Holding History

Maxele Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$427K Buy
+1,680
New +$392K 0.3% 68
2025
Q4 		$352K Buy
1,700
+238
+16% +$47.1K 0.29% 73
2025
Q3 		$271K Buy
1,462
+3
+0.2% +$514 0.23% 82
2025
Q2 		$223K Buy
1,459
+4
+0.3% +$615 0.19% 96
2025
Q1 		$241K Sell
1,455
-36
-2% -$5.63K 0.23% 88
2024
Q4 		$216K Buy
+1,491
New +$231K 0.21% 92
2022
Q3 		$334K Sell
2,045
-15
-0.7% -$2.54K 0.56% 49
2022
Q2 		$366K Sell
2,060
-150
-7% -$26.7K 0.57% 50
2022
Q1 		$392K Sell
2,210
-25
-1% -$4.25K 0.49% 54
2021
Q4 		$382K Buy
+2,235
New +$366K 0.44% 60

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Maxele Advisors's JNJ Position: Q2 2026 in Review

Maxele Advisors opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 1,680 shares worth $427K. The stake represents 0.3% of the portfolio and ranks #68 among its holdings. This is a return to the name: Maxele Advisors previously reported a position in JNJ as recently as Q4 2025.

Maxele Advisors first reported a position in JNJ in Q4 2021 and has held it in 10 quarters since. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Maxele Advisors held 1,680 shares of Johnson & Johnson worth $427K as of Q2 2026.
  • Johnson & Johnson was a new Maxele Advisors position in Q2 2026.
  • Johnson & Johnson made up 0.3% of Maxele Advisors's portfolio in Q2 2026, its #68 holding.
  • Maxele Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 10 quarters since.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Maxele Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.